Compare PWP & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PWP | ATEC |
|---|---|---|
| Founded | 2006 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2020 | 2006 |
| Metric | PWP | ATEC |
|---|---|---|
| Price | $15.65 | $8.76 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $23.50 | $22.00 |
| AVG Volume (30 Days) | 1.3M | ★ 2.5M |
| Earning Date | 05-01-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.31% | N/A |
| EPS Growth | ★ 138.52 | 15.04 |
| EPS | ★ 0.02 | N/A |
| Revenue | N/A | ★ $101,739,000.00 |
| Revenue This Year | $28.86 | $18.97 |
| Revenue Next Year | $18.95 | $16.70 |
| P/E Ratio | $791.00 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.54 | $6.82 |
| 52 Week High | $25.93 | $23.29 |
| Indicator | PWP | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 41.29 | 57.43 |
| Support Level | $15.74 | $7.27 |
| Resistance Level | $19.09 | $13.08 |
| Average True Range (ATR) | 0.85 | 0.39 |
| MACD | 0.13 | 0.17 |
| Stochastic Oscillator | 45.25 | 98.72 |
Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.